Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Change-In-Other-Working-Capital" stands at 0.512 Billion United States Dollars for the trailing twelve months (TTM) period ending 03/31/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.372 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.372 Billion United States Dollars.
The 3 year change is -1.38 Billion United States Dollars.
The 5 year change is -3.25 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Other Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Other Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Other Working Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Other Working Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change In Other Working Capital | 280,205,508,085.11 |